Skip to main content
Top of the Page
___
Speaker Photo


Simon Baron-Cohen, Ph.D.

Director Of The Autism Research Centre
Cambridge University

Professor Sir Simon Baron-Cohen is Director of the Autism Research Centre (ARC) in Cambridge University. He has made contributions to many aspects of autism research and has published over 750 peer reviewed scientific articles. In 1999, he set up the first UK clinic for the late diagnosis of autism in adults. In 2010, he chaired the NICE Guidelines for autism in adults. In 2017, he gave a keynote address to the United Nations on Autism Awareness Day on the topic of Autism and Human Rights. In 2017 he served as President of the International Society for Autism Research. In 2021, he received a knighthood in the New Year’s Honours List for his services to autism. In 2023, the Medical Research Council (MRC) awarded him with the MRC Millennium Medal in recognition of his pioneering MRC-funded research into the prenatal sex steroid theory of autism, his establishment of the ARC, and his work in the public understanding of neurodiversity. In 2026 he was given the Grawemeyer Award in Psychology, the highest prize in the field of psychology, for the same discoveries. He has written 3 popular science books. He is a Fellow of the British Academy, the Academy of Medical Sciences, and the Royal Society of Medicine. His recent book The Pattern Seekers is a celebration of the role autistic people have played in human invention.


BARON-COHEN, SIMON
Speaker Photo


David A. Bennett, MD

Director
Rush University Medical Center

David A. Bennett, MD, is director of the RUSH Alzheimer’s Disease Center and the Robert C. Borwell Professor of Neurological Sciences. The Rush Alzheimer’s Disease Center is a large, free-standing multidisciplinary research and clinical center within Rush Medical College that studies a wide range of common chronic conditions of aging. Studies range from community-based epidemiologic studies across the USA, Brazil and Mexico to phase I-IV clinical trials. Dr. Bennett is internationally known for his research and is the principal investigator of several studies funded by the National Institute on Aging, including the Religious Orders Study, the Rush Memory and Aging Project, and the Pathology, Alzheimer’s and Related Dementias Study in Sao Paulo, Brazil. He also directs the Regional Alzheimer’s Disease Assistance Center for Northern Illinois. He serves on numerous national and international advisory and editorial boards. He recently rotated off membership of the National Advisory Council on Aging for the National Institutes of Health. Dr. Bennett was the winner of the 2018 Potampkin Prize for research on dementia. He has more than 1,500 peer-reviewed manuscript publications, with more than 290,000 citations and an h-index of 246.


BENNETT, DAVID
Speaker Photo


Brianne Bettcher, Ph.D.

Associate Professor
University Of Colorado Anschutz

Dr. Bettcher is an Associate Professor in the Department of Neurology at the University of Colorado (CU) Anschutz. She directs neuropsychology research in the Behavioral Neurology section at CU and oversees the Colorado Aging Brain laboratory. The focus of her research program is at the interface of immune biology, cognitive neuroscience, and neuropsychology, with the primary goals being to elucidate modifiable, immune-mediated factors that will inform early treatments for cognitive decline in late life. 


BETTCHER, BRIANNE
Speaker Photo


Karen Blackmon, PhD

Associate Professor
Geisel School Of Medicine At Dartmouth

Karen Blackmon is an Associate Professor of Psychiatry at Geisel School of Medicine at Dartmouth, Associate Professor of Population Health at Aga Khan University in Kenya, and Co-Chair of the World Health Organization Dementia Assessment Workgroup. Her research focuses on identifying at-risk and resilient cognitive aging with novel tools and biomarkers in Low- and Middle-Income Countries. She is a Principal Investigator on the NIH-funded Brain-START project, which is validating new digital cognitive assessments for dementia detection across Kenya and Pakistan, as well as the Wellcome Leap-funded Brain-Resilience-Kenya study, which employs a mixed-methods approach to identify biopsychosocial factors underlying cognitive resiliency in Kenyan adults. Her clinical efforts aim to streamline early detection, pre-diagnostic care pathways, and brain health lifestyle change for patients with cognitive decline. 


BLACKMON, KAREN
Speaker Photo


Michael Brook, PhD, ABPP-CN

Associate Professor
Northwestern University Feinberg School Of Medicine

Dr. Brook is a board-certified clinical neuropsychologist and an associate professor of psychiatry and behavioral sciences at the Northwestern's University's Feinberg School of Medicine, where he directs the Isaac Ray Research Program in Behavioral Sciences and the Law. Dr. Brook’s research investigates the bio-psycho-social determinants of violence. He has published on topics including the role of neurocognition as a biomarker for violent behavior, relationships between emotion processing and psychopathic personality traits, and the application of public health science to the study of community violence. Clinically, Dr. Brook is a generalist neuropsychologist who sees patients diagnosed with traumatic brain injury,  epilepsy, brain tumors, neurodegenerative, and neurodevelopmental disorders. He also serves as an expert witness to the courts in criminal and civil matters including mitigation, competency, fitness, risk assessment, personal injury, and malpractice.


BROOK, MICHAEL
Speaker Photo


Robyn M. Busch, PhD

Head, Section Of Neuropsychology
Cleveland Clinic

Robyn M. Busch, PhD, ABPP-CN is Head of the Section of Neuropsychology in the Department of Clinical Neurology at Cleveland Clinic and Professor of Neurology at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. She is a staff member in the Cleveland Clinic Epilepsy Center with joint appointments in the Department of Neurology and the Genomic Medicine Institute. Dr. Busch is PI of the Cleveland Clinic Epilepsy Biorepository and Brain Tissue Bank, and her research program seeks to identify factors, including genetic and genomic contributors, that affect neurobehavioral function in patients with epilepsy and to improve prediction of cognitive and behavioral outcomes following epilepsy surgery. The ultimate goal of this work is to develop personalized prognostic models and evidence-based clinical trials to prevent or treat cognitive impairment, improving patient outcomes and quality of life. Dr. Busch also leads several international, multicenter collaborative projects to understand factors associated with cognitive phenotypes in epilepsy and predictors of patient satisfaction following epilepsy surgery.


BUSCH, ROBYN
Speaker Photo


Adam R. Cassidy, PhD

Dr.
Mayo Clinic Rochester

Adam R. Cassidy, PhD, LP, ABPP is a pediatric neuropsychologist and Associate Professor of Psychology and Pediatrics at the Mayo Clinic in Rochester, MN, USA. Dr. Cassidy’s research focuses on understanding and optimizing neurodevelopmental and psychosocial outcomes in at-risk populations, primarily individuals with congenital heart disease (CHD) and children exposed in utero to HIV and antiretroviral medications. He is Past Co-Chair of the Cardiac Neurodevelopmental Outcome Collaborative (CNOC); currently serves as Co-Vice Chair of the CNOC Research Committee; and is a co-author of the 2024 American Heart Association Scientific Statement on the evaluation and management of neurodevelopmental outcomes in CHD. In addition, Dr. Cassidy has an active clinical practice, serves on the Mayo Clinic Children’s Pediatric Heart Program Steering Committee, is a Consulting Editor for the journals Child Neuropsychology, The Clinical Neuropsychologist, and the Journal of the International Neuropsychological Society, and is a member of the Board of Directors of Camp Odayin (a camp for children with heart disease and their families).  


CASSIDY, ADAM
Speaker Photo


Shira Cohen-Zimerman, PhD

Research Scientist
Shirley Ryan AbilityLab

Dr. Shira Cohen-Zimerman is a Research Scientist at Shirley Ryan AbilityLab and a Research Assistant Professor in the Department of Physical Medicine & Rehabilitation at Northwestern University Feinberg School of Medicine. She has over 20 years of clinical and research experience in the areas of cognitive neuroscience, neuropsychology, and neurorehabilitation, with a particular focus on cognitive and emotional outcomes following neurological injury and disease. Her current research focuses on rehabilitation outcomes and patient-centered interventions for individuals with traumatic brain injury (TBI), Long COVID, and other neurological conditions. She has led and contributed to studies examining cognitive rehabilitation, motivation and engagement following brain injury, and the neural basis of behavior, using behavioral, clinical, and neuroanatomical approaches. Dr. Cohen-Zimerman is also leading a growing line of research investigating transcutaneous vagus nerve stimulation (tVNS) in rehabilitation, including ongoing clinical trials evaluating its feasibility and therapeutic potential for cognitive rehabilitation in individuals with TBI. In addition to her research activities, Dr. Cohen-Zimerman is actively engaged in student mentorship, interdisciplinary collaboration, and the advancement of translational rehabilitation research aimed at improving quality of life and long-term functional outcomes for individuals living with neurological conditions.


COHEN-ZIMERMAN, SHIRA
Speaker Photo


Kristine Dell, PhD

Research And Development
Jennifer Moreno- VA San Diego Healthcare System

Dr. Dell is a Research Health Scientist at the Jennifer Moreno-VA San Diego Medical Center with a research emphasis in neuropsychological assessment and traumatic brain injury (TBI) and related disorders, and Assistant Adjunct Professor of Psychiatry at UC-San Diego. She completed her graduate studies at Penn State University-University Park, and then both her predoctoral internship and neuropsychology postdoctoral fellowship in TBI-Cognitive Rehabilitation & Neuropsychological Assessment at the UC-San Diego/VA San Diego training program. She currently serves as principal investigator of a VA Career Development Award entitled "Assessing Cognition with Eye-tracking in Veterans with TBI" (ACE-TBI), and a UC-San Diego awarded pilot grant "Intra-Individual Variability in Spanish Language Cognitive Assessment" (ISLA).


DELL, KRISTINE
Speaker Photo


Stephen Gillaspy, PhD

Deputy Chief, Health Policy & Healthcare Financing
American Psychological Association

Stephen Gillaspy, PhD is a licensed clinical psychologist with extensive experience integrating psychological services into larger healthcare systems. Dr. Gillaspy is recognized throughout the field of clinical psychology for his hard work and dedication as a Health Psychologist, as well as a vital member of American Psychological Association (APA) staff, serving as the Senior Director of Health and Health Care Financing August 2019 – December 2024, and now serving as the Deputy Chief for Health Policy and Healthcare Financing. He has also been long-standing, active representative of APA to the American Medical Association, and currently serves as the Alternate Advisor to the Relative Value Update Committee (RUC) and the CPT Editorial Panel. Prior to joining APA staff, Dr. Gillaspy was a Professor and Director of Pediatric Psychology in the Department of Pediatrics at the University of Oklahoma, College of Medicine. During his tenure in the Section of General and Community Pediatrics at the University of Oklahoma Health Sciences Center (OUHSC), he served as the Director of Research, the Director Clinical Psychology, and Associate Section Chief. He is also a past President of the Oklahoma Psychological Association (OPA), served as Director of the Oklahoma Tobacco Helpline, and has authored or co-authored numerous articles published in scientific journals.


GILLASPY, STEPHEN
Speaker Photo


Joshua Grill, Ph.D.

Professor
UC Irvine

Dr. Grill has been the recipient of the National Alzheimer’s Coordinating Center Junior Investigator Award, the Alzheimer’s Association Turken Research Prize, the Community Spirit Award from OPICA Adult Day Services, and the P. Gene and Elaine Smith Term Chair in Alzheimer’s Disease Research. He has been funded by the National Institute on Aging, the National Institute of Neurological Disorders and Stroke, the Alzheimer’s Association, the BrightFocus Foundation, the Hartford Foundation, the American Federation for Aging Research, and the University of California. He is the co-leader of the Internal Ethics Committee and the Recruitment Unit for the NIA-funded Alzheimer's Clinical Trial Consortium. He is the Chair of the Internal Ethics Committee for the Alzheimer’s Disease Cooperative Study. He is a member of the Scientific Advisory Board for Maria Shriver’s Women’s Alzheimer’s Movement and for HFC (formerly Hilarity for Charity). In 2017, he co-chaired a workgroup as part of the NIH’s Inclusion Across the Lifespan workshop, a congressional mandate in the 21st Century Cures Act (P.L. 114-255). He is part of a working group sponsored by the National Institute on Aging and the Alzheimer’s Association charged with creating a national strategy for recruitment to Alzheimer’s disease clinical research. In 2021, he was an invited presenter and contributor to "A Workshop on Biomarkers and Other Pre-Clinical Diagnostics of Alzheimer's Disease," sponsored by the National Institute on Aging and convened by the National Academies of Science, Engineering, and Medicine.


GRILL, JOSHUA
Speaker Photo


Joseph Gullett, Ph.D.

Assistant Professor
University Of Florida

Clinical Focus: Dr. Gullett conducts adult neuropsychological assessments across a broad range of ages and referral reasons. The majority of his neuropsychological assessment referrals come from the Neurology department and focus on older adults with changes in cognition. Research Focus: Dr. Gullett’s research is focused on (1) the use of Artificial Intelligence methods to predict intervention outcomes and disease progression in older adults with and without mild cognitive impairment (MCI) and (2) the relationship of white matter microstructure with clinical disorders and their associated neuropsychological function.


GULLETT, JOSEPH
Speaker Photo


Trevor A. Hall, PsyD, ABPdN

Professor Of Pediatrics, School Of Medicine
Oregon Health & Science University

Dr. Hall is a board certified pediatric neuropsychologist who specializes in providing care for children and adolescents with central nervous system complications. He is the Associate Director of the Pediatric Critical Care & Neurotrauma Recovery Program (PCCNRP) at Doernbecher Children’s Hospital. Clinically, Dr. Hall works to develop and effectively communicate an understanding of neurocognitive functioning in children and adolescents admitted to the Pediatric Intensive Care Unit (PICU) for a brain related injury or illness, so that specific evidence-based treatment/intervention strategies can be developed with the goal of optimizing recovery. In addition to his clinical work, Dr. Hall is actively engaged in clinical research through the PCCNRP research lab and he participates in the training of neuropsychology practicum students, interns and postdoctoral fellows. In his personal life, Dr. Hall enjoys spending time with his wife and two sons. He also enjoys backpacking/camping, mountain climbing, snowboarding, golf, and all things related to science-fiction (especially if the science fiction is related to Star Wars).


HALL, TREVOR
Speaker Photo


Dustin Hammers, PhD

Associate Professor
Indiana University

Dustin Hammers is a board-certified clinical neuropsychologist and Associate Professor in the Department of Neurology at Indiana University (IU). Dr. Hammers is the lead neuropsychologist involved in the NIA-funded Longitudinal Early-Onset Alzheimer’s Disease Study (LEADS), and he is currently the Principal Investigator on both the NIA- and Alzheimer’s Association- funded study Lifestyle Interventions for the Treatment of Early-Onset AD Study (LITES), as well as the NIA R01 funded study Subjective Cognitive Impairment and Practice Effects (SCI-PE). Among his research interests are remote cognitive assessments, including teleneuropsychology and digital cognitive assessments. Relatedly, he is currently a member of the Global CEO-Initiative on Alzheimer’s Disease Working Group for the Development of Appropriate Use Criteria for Remote Digital Cognitive Assessments. He currently serves as Section Editor of Alzheimer’s & Dementia: Diagnosis, Assessment, & Disease Monitoring, is the past Chair of the American Psychological Association’s Committee on Rural Health, and is currently a Member-At-Large for the International Neuropsychological Society – Dementia Special Interest Group.


HAMMERS, DUSTIN
Speaker Photo


Dan Y. Han, PsyD, FANA, FRSM, FRSPH

Professor Of Neurology, Neurosurgery, And Physical Medicine & Rehabilitation
University Of Kentucky College Of Medicine

Dr. Dan Han is Professor of Neurology, Neurosurgery, and Physical Medicine & Rehabilitation at the University of Kentucky College of Medicine and Chief of the Division of Neuropsychology. Dr. Han is a James B. Beam Institute Faculty Fellow and Fellow of the American Neurological Association, National Academy of Neuropsychology, Royal Society for Public Health, and Royal Society of Medicine. His research spans federally funded neurotechnology and neurorehabilitation, brain-computer interfaces, and chemosensory perception, alongside neurogastronomy and AI & robotics consulting for Fortune 500 and Fortune Global 500 companies. He has published a series of peer-reviewed work on AI, large language models, and neuroethics, and has delivered invited plenaries on AI in healthcare at national venues since before the public rollout of generative AI. Dr. Han's work has been sponsored by the National Institutes of Health, the Department of Defense, the Department of Education, foundation grants, industry clinical trials, and national think tanks, focusing on brain-behavior relationships, program development, and neuroeconomics. His work has been featured across national and international media including Newsweek, National Geographic, The Atlantic, The Wall Street Journal, the APA’s Monitor on Psychology, CNN with Dr. Sanjay Gupta, NPR, the BBC, ABC Australia, CBC Canada, NBC, Aspen IDEAS: Health, and Apple Podcasts and Spotify, with coverage syndicated globally across 17 countries in 12 languages.


HAN, DAN
Speaker Photo


Laura Hancock, PhD


Cleveland Clinic

Dr. Hancock is a board-certified clinical neuropsychologist in the Mellen Center for Multiple Sclerosis at the Cleveland Clinic. She is a clinician, educator, and researcher with expertise in Multiple Sclerosis. Her research focuses mainly on various aspects of cognitive and emotional functioning in people living with MS (PwMS). Current projects include further investigating cognition in aging PwMS, investigating cognitive phenotypes in PwMS, and exploring factors that differentiate older PwMS from older people with Alzheimer’s disease. She is also leading an international working group to establish consensus diagnostic criteria for cognitive impairment in MS.


HANCOCK, LAURA
Speaker Photo


Kristina Hardy, PhD

Program Director, Division Of Clinical Research, NINDS
National Institutes Of Health

Kristina K. Hardy, Ph.D., is a Program Director in the Division of Clinical Research at the National Institute of Neurological Disorders and Stroke (NINDS). Prior to joining NINDS in 2022, she was a pediatric neuropsychologist at Children's National Hospital and a tenured Professor in the Departments of Psychiatry & Behavioral Sciences and Pediatrics at the George Washington University School of Medicine. Dr. Hardy received her bachelor's degree from Amherst College and earned her doctorate in clinical psychology at Duke University. Following a pre-doctoral internship year at the Medical University of South Carolina, she returned to Duke to complete a fellowship in pediatric neuropsychology, and later joined the faculty there prior to transitioning to Children's National in 2010. Dr. Hardy has expertise in developmental and acquired difficulties with attention, learning, and executive functioning. Her clinical research program was focused primarily on identifying factors associated with neurocognitive difficulties in survivors of pediatric cancer and children with neurofibromatosis, as well as developing and evaluating interventions for these difficulties. In addition, Dr. Hardy has participated in research with neurodevelopmental populations including ADHD and Autism Spectrum Disorder. She was also heavily involved in team science initiatives, including clinical research conducted with the Children's Oncology Group, where she served as Vice-Chair of the Behavioral Science Discipline and Co-Chair of the Neurotoxicity subcommittee of the Cancer Control Domain. Dr. Hardy has a particular interest in the use of technology in neuropsychological health, including computerized assessment and cognitive training programs, as well as the development and validation of cognitive assessments for use in clinical trials. At NINDS, Dr. Hardy manages a portfolio of research centered around cognitive and neurodevelopmental outcomes of pediatric neurological conditions.


HARDY, KRISTINA
Speaker Photo


Bruce P. Hermann, Ph.D.

Professor Emeritus
University Of Wisconsin SChool Of Medicine And Public Health

Dr. Hermann's clinical and research career has been devoted to understanding the effects of epilepsy and epilepsy surgery on cognition and behavior in children and adults. For the past 30 years his research group has focused efforts in three areas: 1) characterizing the cognitive, psychiatric and neuroimaging abnormalities of adults with chronic temporal lobe epilepsy and following their course prospectively, 2) characterizing the fand the effects of epilepsy on neurodevelopmental trajectories, and 3) investigating the cognitive and brain aging processes in middle aged and older persons with epilepsy. 


HERMANN, BRUCE
Speaker Photo


Christen Holder, PhD


UTHSC/LeBonheur Children's Hospital

Dr. Holder is a Professor at the University of Tennessee Health Science Center and the Director of Neuropsychology for Le Bonheur Children's Hospital in Memphis, TN. Le Bonheur is part of the UT Health Science Center Internship Training Consortium, and Dr. Holder is the training representative to the consortium for the hospital. Dr. Holder has served NAN in several roles over the years and is currently the NAN President-Elect.


HOLDER, CHRISTEN
Speaker Photo


Karen Holdridge, MPH


LILLY

Karen Holdridge, MPH, is a clinical research scientist at Eli Lilly and Company, specializing in drug development for cognitively unimpaired Alzheimer’s disease populations with over 20 years’ drug development experience. She is currently the lead clinical research scientist for the TRAILBLAZER-ALZ 3 study of donanemab in cognitively unimpaired AD. Previously, she led the scientific communications team for the solanezumab EXPEDITION studies, supporting medical and regulatory strategy.


HOLDRIDGE, KAREN
Speaker Photo


Grant L. Iverson, Ph.D.

Professor
Harvard Medical School

Dr. Grant Iverson is a clinical neuropsychologist at Mass General Brigham Spaulding Rehabilitation and Massachusetts General Hospital. He is a Professor in the Department of Physical Medicine and Rehabilitation at Harvard Medical School. He is the Director of the Neuropsychology Outcome Assessment Laboratory at Mass General Brigham Spaulding Rehabilitation. For more than 20 years, he has conducted research relating to the reliability, validity, and clinical accuracy of neuropsychological assessment. Since 2006, he has led a programmatic research effort to develop and evaluate new evidence-based psychometric criteria for mild cognitive impairment in psychiatry and neurology. This research program has resulted in a new methodology for interpreting neuropsychological test results in day-to-day clinical practice. The new methodology improves accuracy and reduces false positive diagnoses of mild cognitive impairment. Over the course of his career, he has published more than 640 empirical articles, reviews, and book chapters. He served as the Chair for the Canadian Psychological Association Section on Clinical Neuropsychology from 2003-2010. He served as an Advisor to the Neurocognitive Disorders Workgroup (Traumatic Brain Injury) for the Diagnostic & Statistical Manual of Mental Disorders, 5th Edition (DSM-V) (2011-2012). He also served as a founding member of the Traumatic Brain Injury Subcommittee of the Defense Health Board, a chartered civilian advisory board to the United States Secretary of Defense (2008-2011). He served on the Board of Governors of the International Neuropsychological Society from 2008-2011. He served on the Board of Governors for the International Brain Injury Association from 2012-2020. He served as the President of the National Academy of Neuropsychology in 2015, and as a member of the Board of Governors from 2014-2018. He was awarded the North American Brain Injury Society Clinical Research Award in 2026.


IVERSON, GRANT
Speaker Photo


Emily Jacobs, Ph.D.

Professor
UC Santa Barbara

Emily Jacobs is a Professor of Neuroscience at UC Santa Barbara and Director of the Ann S. Bowers Women's Brain Health Initiative. Her body of research is redefining our understanding of the brain’s capacity to undergo dynamic neuroanatomical changes and plasticity well into adulthood. In 2024 her team published the first detailed map of the human brain across pregnancy and she leads several multi-center studies on neurological changes tied to menopause. Prior to UCSB, she held a faculty appointment at Harvard Medical School and the Department of Medicine/Division of Women's Health at Brigham & Women's Hospital. Dr. Jacobs' serves on the Steering Committee of the Coalition for Women’s Brain Health, the Milken Institute’s Women’s Health Network, the Foundation for Women’s Health, and the WHAM Research Collaborative to drive the national and international agenda on women’s health research. Dr. Jacobs has been named a National Institutes of Health Women's Health Fellow, a National Academy of Sciences Frontiers of Science Fellow and one of Science News' “Top 10 Scientists” to watch. Outside of the lab, Dr. Jacobs’ team partners with K-12 groups to advance girls' representation in STEM. You can find her work in the The New York Times, National Geographic, Scientific American, NPR, BBC, Radiolab, TED, Netflix, and MasterClass. She is a graduate of Smith College and UC Berkeley.


JACOBS, EMILY
Speaker Photo


Susanne Jaeggi, Ph.D.

Professor
Northeastern University

Susanne M. Jaeggi is Professor at Northeastern University, where she directs the Brain Game Center for Mental Fitness and Well-Being and the SoundMind Collaboratory. She is also affiliated with the Institute for Cognitive and Brain Health, and the Departments of Psychology, Applied Psychology, and Music. Before joining Northeastern, she was Professor in Education and Cognitive Science at the University of California, Irvine, where she directed the Working Memory and Plasticity Lab for over a decade. She received PhDs in Cognitive Psychology and Neuroscience, as well as a ‘Habilitation’ in Psychology from the University of Bern in Switzerland, and she conducted postdoctoral work in Cognitive Neuroscience at the University of Michigan. Susanne Jaeggi’s research program focuses on understanding individual differences in working memory, executive functions, and related cognitive domains, as well as their malleability across the lifespan using experimental and neuroscientific approaches. Because of the relevance of those cognitive domains in educational settings and daily life, her major work has focused on the development of assessments and interventions, and the extent to which working memory and executive functions can be improved with both, experience and targeted training. Furthermore, she is interested in understanding the underlying mechanisms of learning and cognitive training, and determining for what individuals and populations cognitive training is most effective and why. Her work has been funded by NIH (NIA, NMIH), NSF, ONR, IES, and the Advanced Education Research and Development Fund (AERDF; EF+Math Program). Contact Info: s.jaeggi@northeastern.edu. Website: https://bgc.provost.northeastern.edu. Google Scholar: https://scholar.google.com/citations?user=xEbuGsAAAAAJ&hl=en&authuser=1


JAEGGI, SUSANNE
Speaker Photo


Kyle Jennette, PhD, MA

Assistant Professor Of Clinical Psychiatry, Neurology, And Surgery
University Of Illinois - Chicago

Dr. Jennette is Clinical Neuropsychologist and Assistant Professor of Clinical Psychiatry, Neurology and Transplant Surgery at the University of Illinois Chicago College of Medicine. Dr. Jennette earned his bachelor’s degree in psychology from Flagler College, master’s degree in gerontology from the University of South Florida, and Ph.D. in Clinical Psychology from the University of Wisconsin - Milwaukee. He completed his Clinical Psychology Internship at the University of Chicago Medical Center and Postdoctoral Fellowship in Clinical Neuropsychology at the University of Illinois Chicago and UI Health. Dr. Jennette is the Director of the UIH Transplant Neuropsychology Service and Interdisicplinary Memory Clinic, and coordinator for multiple interdisciplinary and embedded clinics, including the Embedded Adult Sickle Cell Clinic and Emergency Medicine Consult Service. Dr. Jennette's clinical interests include neurocognitive functioning in complex medical popualtions, social determinants of health, end stage organ disease, transplant, neurodegenerative disease, and aging.


JENNETTE, KYLE
Speaker Photo


W. Curt LaFrance, Jr., M.D., MPH

Professor / Director
Brown University / VA Mind Brain Program

Dr. LaFrance is professor of psychiatry and neurology at Brown University Medical School, Director of the VA Mind Brain Program and Program Director for VA NEXCSS Tele-Neuropsychiatry Clinic. He was the inaugural director of neuropsychiatry and behavioral neurology at Rhode Island Hospital. He trained in Brown’s combined neurology/psychiatry residency and is double boarded. He is the ILAE Neuropsychiatry Commission Chair and has chaired ILAE and American Epilepsy Society NES Task Forces. He has received grants from EF, AES, Foundations, VA, DoD, and a NINDS K23 Award. He trains clinicians nationally using distance supervision in neurobehavioral therapy (NBT), a whole-person treatment using the Taking Control Workbook. His research focuses on developing new biomarkers and treatments for neuropsychiatric disorders. A goal of his work at Brown, nationally and internationally, has been to bridge neurology and psychiatry clinical practice and scientific research and to dissolve arbitrary boundaries between the two fields.


LAFRANCE, JR., W. CURT
Speaker Photo


Andrew Lim, M.D.

Associate Professor
University Of Toronto

Dr. Lim is a sleep neurologist at Sunnybrook Health Sciences Centre and associate professor of neurology at the University of Toronto.  He is PI of the Ontario Sleep Health Study, co-PI of the Canadian Consortium on Neurodegeneration in Aging Sleep Team, and PI of several studies investigating the relationship between sleep and brain health in the Rush Memory and Aging Project and Canadian Longitudinal Study of Aging.  His research focuses on understanding the bi-directional links between sleep and circadian disruption and neurodegenerative disorders, and his clinical practice focuses on older adults with and without neurodegenerative diseases who are experiencing sleep and circadian rhythm disturbances.  He obtained his medical degree and completed a neurology residency at the University of Toronto, and completed as Master of Medical Science and clinical fellowship training in sleep medicine at Harvard Medical School.


LIM, ANDREW
Speaker Photo


Francesca V. Lopez, PhD


VA San Diego / UC San Diego

Francesca V. Lopez is a postdoctoral fellow at VA San Diego Healthcare System (VASDHS) and UC San Diego. She earned her Ph.D. in Clinical and Health Psychology with a specialization in neuropsychology at the University of Florida following a clinical internship at VASDHS/UC San Diego. Her research focuses on mechanisms of brain and behavior change in aging and neurodegeneration with a particular interest in how lifetime risk and resilience factors influence the identification of early markers of change and critical windows for intervention.


LOPEZ, FRANCESCA
Speaker Photo


Tatiana Marcal, MD

Senior Director, Medical Affairs And Clinical Programs
Alzheimer's Association

Dr. Tatiana Marcal is Senior Director of Medical Affairs & Clinical Programs at the Alzheimer’s Association, where she leads initiatives focused on clinical education, implementation of evidence-based dementia care, and the integration of emerging diagnostic tools into clinical practice. Prior to joining the Alzheimer’s Association, she worked in clinical and medical affairs at C2N Diagnostics, supporting clinical utility and implementation of Alzheimer’s disease blood-based biomarkers, including real-world evidence and healthcare claims analyses related to biomarker access and adoption. Her earlier experience includes clinical research at Stanford Medicine and medical affairs within the biotechnology industry, with work spanning Alzheimer’s disease, neurology, rare disease, and diagnostics. She received her Doctor of Medicine degree from Pavlov First Saint Petersburg State Medical University.


MARCAL, TATIANA
Speaker Photo


Shawn McClintock, PhD

Scientific Director, Perot Foundation Neuroscience Translational Research Center
UT Southwestern Medical Center

Dr. Shawn M. McClintock is a Clinical Neuropsychologist and Scientific Director of the Perot Foundation Neuroscience Translational Research Center in the Peter O’Donnell Jr. Brain Institute at UT Southwestern Medical Center. He is a Professor with Tenure and holds the Lydia Bryant Test Distinguished Professorship in Psychiatric Research in the Division of Psychology, Department of Psychiatry at UT Southwestern. Dr. McClintock received his Ph.D. in Clinical Psychology (2006) from UT Southwestern Medical Center. He completed postdoctoral training in clinical neuropsychology and mood disorders research as a National Institute of Mental Health (NIMH) T32 Postdoctoral Fellow at UT Southwestern Medical Center, and he completed postdoctoral training in brain stimulation and therapeutic modulation at Columbia University / New York State Psychiatric Institute. Subsequently, he was appointed a National Institutes of Health (NIH) KL2 Clinical Scholar and received his M.S. in Clinical Sciences (2011) from UT Southwestern Medical Center. He is a globally recognized expert in the neurocognitive effects of major depressive disorder and neuromodulation therapeutics. He has received grant funding from the National Institutes of Health and the Brain and Behavior Foundation. He serves on the editorial board of the Journal of ECT. Dr. McClintock has published over 150 peer-reviewed articles and co-edited the book Neuropsychology of Depression.


MCCLINTOCK, SHAWN
Speaker Photo


Karin McCoy, Ph.D.


South Texas Veterans Health Care System

Karin JM McCoy, Ph.D., ABPP, is the Neuropsychology Section Chief and Training DIrector of the Clinical Neuropsychology Postdoctoral Fellowship Training Program at the South Texas Veterans Health Care System (aka San Antonio VA). The two-year training program has four neuropsychology fellows, and 11 neuropsychologists, of whom five are currently board certified, and one of whom provides assessment in Spanish. Dr. McCoy values excellence in training; she serves as an APA accreditation site visitor and as one of NAN's delgates to the Minnesota Update Conference. Previously she served on the Clinical Neuropsychology Synarchy workgroup to provide feedback to APA regarding neuropsychology competencies. Dr. McCoy is actively involved in NAN; she has served as Program Chair, Member-at-Large, Treasurer, and is currently President Elect. While Program Chair, she established the first "trainee track" (with presentations relevant to, and specifically for, trainees) at the NAN conference.


MCCOY, KARIN
Speaker Photo


Victoria Merritt, Ph.D.

Research Health Scientist
VA San Diego Healthcare System

Dr. Victoria Merritt earned her Ph.D. in Clinical Psychology from The Pennsylvania State University and completed her internship and post-doctoral fellowship at VA San Diego Healthcare System/UC San Diego. She is currently a Research Health Scientist at VA San Diego and as Associate Professor in the Department of Psychiatry at UC San Diego. Dr. Merritt’s research interests include examining predictors of recovery and outcome following traumatic brain injury (TBI). Another major emphasis of her research program has been to evaluate long-term outcomes following TBI and to better understand the association between TBI, other risk factors, and the development of Alzheimer’s disease and related dementias (ADRD). She has been an active investigator within the VA Million Veteran Program (MVP) since 2019 and has extensive experience working with electronic health record (EHR) data to develop and validate clinical phenotypes (e.g., TBI, ADRD). She is funded by the VA Office of Research and Development (ORD), Department of Defense (DoD), and National Institutes of Health (NIH).


MERRITT, VICTORIA
Speaker Photo


Sarah Morrow, MD, MS, FRCPC


University Of Calgary

Sarah A. Morrow is a Professor in the Department of Clinical Neurosciences at the University of Calgary and is the Director of the Calgary MS Program. She received her MD from the University of Calgary and completed her residency training in neurology at Western University. This was followed by a clinical fellowship in MS at the London MS clinic at Western University and a research fellowship on Cognition and MS at the Jacobs Neurologic Institute in Buffalo NY. Dr. Morrow has also completed a Master of Science in Epidemiology at the State University of New York at Buffalo. Dr. Morrow’s has over 150 peer-reviewed publications in the area of MS. Her research has established the importance of screening for cognitive impairment as well as the impact it can have on the day-to-day life of persons with MS. She is a board member as well as [art of the steering committee of the International MS Cognition Society (IMSCOGS), is a Board member for the Consortium of MS Centers and on the editorial board of the International Journal of MS. She is also on the steering committee of MS in the 21 Century, an international collaboration being health care practitioners and persons living with MS with the aim of defining how MS treatment and standard of care should look in the 21st century.


MORROW, SARAH
Speaker Photo


Joshua Owens, PhD

Post Doctoral Fellow
VA San Diego Healthcare System/ University Of California

Dr. Joshua H. Owens is a Neuropsychology Postdoctoral Fellow at the VA San Diego Healthcare System and the University of California, San Diego. He earned his PhD in Clinical Psychology, with a concentration in Clinical Neuropsychology, from the University of Florida and completed his predoctoral internship at Emory University. Dr. Owens began his research career by applying advanced statistical methods to examine environmental contributors to racial disparities in cognitive and neurological outcomes among older adults. This work was supported by the National Institute on Aging, first through a competitive supplement from the University of Florida Alzheimer’s Disease Research Center and later through a T32 Clinical and Translational Science training grant. Through his clinical training, he developed a particular interest in traumatic brain injury (TBI) and rehabilitation following brain injury. Recognizing a gap in the literature, he expanded his research program to apply his expertise in social determinants of health to TBI recovery and rehabilitation. His current research leverages data from the VA Million Veteran Program and VA electronic health records to identify environmental and other nonbiological contributors to outcomes and recovery following military-related TBI. The ultimate goal of his work is to inform clinical practice and policy interventions that improve recovery and reduce disparities in care.


OWENS, JOSHUA
Speaker Photo


Ronald Petersen, MD, PhD

Professor
Mayo Clinic

Dr. Ronald C. Petersen received a Ph.D. in Experimental Psychology from the University of Minnesota and graduated from Mayo Medical School in 1980.  He completed an internship in Medicine at Stanford University Medical Center and returned to the Mayo Clinic to complete a residency in Neurology.  That was followed by a fellowship in Behavioral Neurology at Harvard University Medical School/Beth Israel Hospital in Boston, Massachusetts.  Dr. Petersen joined the staff of the Mayo Clinic in 1986 and became a Professor of Neurology in 1996.  In 2000 he was named the Cora Kanow Professor of Alzheimer’s Disease Research and Mayo Clinic Distinguished Investigator in 2011. He is currently the Emeritus Director of the Mayo Alzheimer’s Disease Research Center and the Director of the Mayo Clinic Study of Aging and has authored over 1500 peer-reviewed articles on memory disorders, aging, and Alzheimer’s disease.  Dr. Petersen is one of the recipients of the 2004 MetLife Award for Medical Research in Alzheimer’s Disease and the 2005 Potamkin Prize for Research in Picks, Alzheimer’s and Related Disorders of the American Academy of Neurology.  In 2012 he received the Khachaturian Award and the Henry Wisniewski Lifetime Achievement Award in 2013 from the Alzheimer’s Association.  In 2011 he was appointed by the Secretary of Health and Human Services to serve as the Chair of the Advisory Committee on Research, Care and Services for the National Alzheimer’s Disease Plan, and in 2014, he was appointed to the World Dementia Council by the UK government.


PETERSEN, RONALD
Speaker Photo


Matthew Phillips, Psy.D.

Assistant Professor Of Clinical Psychiatry And Neurology
University Of Illinois College Of Medicine

Dr. Phillips is an Assistant Professor of Clinical Psychiatry and Neurology at the University of Illinois College of Medicine/Hospital and Health Sciences System. Within this role, his clinical interests include pre- and post-surgical neuropsychological evaluation of patients undergoing neurosurgical intervention (i.e., resections, Deep Brain Stimulation, revascularization), epilepsy, movement disorders, and complex neurological/medical disorders. His research interests broadly focus on better understanding the relationship between subjective cognitive concerns and objective neuropsychological outcomes, the psychometric/diagnostic properties and clinical utility of neuropsychological tests (e.g., performance validity testing, personality assessment), and the neuropsychological sequelae of adult ADHD. As an early career neuropsychologist, he has also taken a keen interest in understanding how digit tools and novel technological advancements can support clinical efficiency and increase patient access to care.


PHILLIPS, MATTHEW
Speaker Photo


Elizabeth M. Pieroth, PsyD, ABPP, MPH

Neuropsychologist
Private Practice

Elizabeth M. Pieroth, PsyD, ABPP, MPH is a Board Certified Neuropsychologist. Until her recent move out of state, she was the Director of the Concussion Program at Midwest Orthopaedics at Rush and Rush University Medical Center. She has been evaluating individuals with TBI for nearly 30 years. For more than 20 years she was the concussion specialist for the Chicago Bears, Blackhawks, White Sox, Red Stars, Fire, Hounds & Steel, the Rockford IceHogs, Indy Fuel and the MLB Umpires Association. Dr. Pieroth remains the Co-Director of the NFL Neuropsychology Consulting Program and the Director of the Concussion Program for both the National Women’s Soccer League and the Professional Women’s Hockey League. She is a member of the NFL Head, Neck and Spine Committee, the US Soccer Concussion Task Force, and the Amateur Hockey Association of Illinois Safety Committee. Dr. Pieroth also has a Masters in Public Health, has published on concussion management and filmed a TEDx talk on concussion treatment.


PIEROTH, ELIZABETH
Speaker Photo


Neil H. Pliskin, PhD

Neuropsychologist
University Of Illinois Chicago

Dr. Neil Pliskin is a board certified clinical neuropsychologist and Professor Clinical Psychiatry and Neurology at the University of Illinois College of Medicine. Dr. Pliskin serves as Director of Neuropsychology services at UI Health and has had 35 years of experience working as a clinical neuropsychologist and directing clinical neuropsychology training programs. Dr. Pliskin is past President of the Society for Clinical Neuropsychology of the American Psychological Association and has served as APA advisor to the AMA/CPT Health Care Professionals Advisory Committee since 2009. He is a fellow of the American Psychological Association and the National Academy of Neuropsychology. He was awarded a Presidential Citation by the American Psychological Association in 2010 for dedicated service to the profession “as an advocate, scientist, educator and practitioner of clinical neuropsychology”. He was awarded 2023 “Distinguished Neuropsychologist” by the American Academy of Clinical Neuropsychology.


PLISKIN, NEIL
Speaker Photo


Catherine E. Price, Ph.D.

Professor
University Of Florida

Dr. Catherine Price is Professor and Board-Certified Neuropsychologist in the Department of Clinical and Health Psychology, and the Department of Anesthesiology, at the University of Florida. She is an independent NIH investigator studying neuroimaging and neuropsychology predictors of cognitive decline for older adults with and without neurodegenerative disorders electing surgeries with anesthesia. Her research expertise involves dementia, movement disorders, perioperative cognitive disorders, and neuroimaging methods. She currently holds an NIH leadership grant to develop the Perioperative Cognitive Anesthesia Network (PeCAN) for Alzheimer's Disease and Related Dementias (ADRD) at the University of Florida. This program provides a) perioperative clinical care to patients with ADRD electing surgery, b) interdisciplinary training to residents and fellows in anesthesiology, neurology, and neuropsychology, and 3) perioperative research opportunities for those interested in perioperative cognitive disorders. She is an elected Fellow within the American Psychological Association, the 2021 International Neuropsychological Society Arthur Benton Mid-Career Awardee for her contribution to the field of neuropsychology in the area of perioperative cognitive medicine. She is also the prior Chair of the 2022-2024 Perioperative Cognitive and Delirium Professional Interest Group of the Alzheimer's Association International Society to Advance Alzheimer's Research and Treatment (ISTAART). Her career goal is to improve evidence-based perioperative care for older adults with ADRD and neurodegenerative disorders such as Parkinson’s disease who need surgery with anesthesia. She is an advocate of preventative medicine and establishing routine preoperative cognitive screening and delirium assessments within hospital settings.


PRICE, CATHERINE
Speaker Photo


Emily Rogalski, PhD

Dr.
University Of Chicago

Dr. Emily Rogalski is the Rosalind Franklin Professor of Neurology at the University of Chicago, where she directs the Healthy Aging & Alzheimer’s Research Care (HAARC) Center, an aging and dementia research hub dedicated to discovering factors that promote resilience, resistance, and increased healthspan. She is a clinical and cognitive neuroscientist whose work spans exceptional aging through Alzheimer’s and Related Dementias. Using a multimodal approach, she studies two complementary perspectives on aging: primary progressive aphasia (PPA), in which neurodegenerative disease disrupts the language network, and SuperAging, in which some older adults appear resistant to the memory decline often associated with typical aging. Her PPA research has helped characterize the clinical and anatomical features of the syndrome, identify factors associated with disease progression, and refine understanding of language network organization. She has also pioneered care-focused research to maximize communication and quality of life for people living with PPA and related dementias, including leading development of Communication Bridge, a telemedicine-based intervention for people with PPA and their communication partners. Rogalski also operationalized the SuperAging phenotype and now leads the international, multisite SuperAging Research Initiative, which seeks to identify biological, molecular, genetic, and psychosocial factors that support exceptional memory, extended healthspan, and resistance to Alzheimer’s disease or its effects.


ROGALSKI, EMILY
Speaker Photo


Robert M. Roth, Ph.D.

Professor Of Psychiatry
Dartmouth Health

Dr. Roth is Professor of Psychiatry at the Geisel School of Medicine at Dartmouth. He is Director of Adult Neuropsychology and Director of Clinical Neuropsychology Training at Dartmouth Health. He has extensive experience in the neuropsychological evaluation of people with neurological, psychiatric, and complex neuropsychiatric conditions. For over 25 years, his research has focused on the assessment and neural underpinnings of executive and other cognitive dysfunction in neurologic and psychiatric conditions, with over 170 scientific publications. He served as Chair of the National Academy of Neuropsychology (NAN) Clinical Research Grants committee for six years and is the current President of NAN.


ROTH, ROBERT
Speaker Photo


Juan A. Serrano, Psy.D.

Clinical Neuropsychologist
Banner Sun Health Research Institute

Juan A. Serrano-Salcedo, PsyD, is a bilingual (Spanish and English) clinical neuropsychologist at Banner Sun Health Research Institute in Sun City, Arizona, where he evaluates Spanish- and English-speaking older adults in a specialty memory and movement disorders clinic. He earned his doctorate with distinguished honors from Albizu University in Puerto Rico and completed his postdoctoral fellowship in clinical neuropsychology under Antonio E. Puente, PhD, with an emphasis on cross-cultural assessment. He volunteers at the national level, serving the Hispanic Neuropsychological Society as Member-at-Large on the Board of Directors and as current Chair of the Communication Committee, where his work centers on raising the visibility of issues affecting Hispanic and Latinx communities in neuropsychology and amplifying the work of emerging professionals and students from underrepresented backgrounds. He is the Arizona State Representative for the Early Career Neuropsychologist Committee of APA's Society for Clinical Neuropsychology and a contributor on cross-cultural assessment to an American Psychological Association working group developing professional practice guidelines in forensic assessment. He is also a graduate of NAN's Leadership Ambassador Development (LEAD) Program, a curriculum in leadership and advocacy for early career neuropsychologists.


SERRANO, JUAN
Speaker Photo


Jason Soble, Ph.D.

Professor Of Clinical Psychiatry And Neurology
University Of Illinois At Chicago

Dr. Soble is a Professor of Clinical Psychiatry and Neurology at the University of Illinois Chicago College of Medicine. He also is board certified in Clinical Neuropsychology by the American Board of Professional Psychology (ABPP) and a Fellow of the American Psychological Society (Division 40: Society for Clinical Neuropsychology). He received his bachelor’s degree in Psychology as well as his master’s degree and Ph.D. in Counseling Psychology from the University of Illinois at Urbana-Champaign. He completed his internship and postdoctoral fellowship in Clinical Neuropsychology at the James A. Haley VA Hospital in Tampa, FL. Prior to joining the faculty at UIC, he was a VA Staff Neuropsychologist at the South Texas Veterans Healthcare System in San Antonio, TX. His clinical interests include pre/post-neurosurgical assessment and evaluating adults with complex neurological and neuropsychiatric disorders, epilepsy, and traumatic brain injury. His research investigates the psychometric/diagnostic properties and clinical utility of neuropsychological tests, especially performance validity tests, as well as neuropsychological sequalae associated psychiatric (e.g., ADHD) and neurological disorders (e.g., electrical shock injury; cerebrovascular disease).


SOBLE, JASON
Speaker Photo


Leah Somerville, Ph.D.

Professor
Harvard University

Leah Somerville is the Grafstein Family Professor of Psychology at Harvard University, a Harvard College Professor (Endowed 2021-2026), and faculty in the Center for Brain Science. Her research focuses on characterizing adolescent brain development, and the consequences of brain development on psychological functioning and well being. This work integrates behavioral, computational, and neuroimaging approaches, including conducting the Human Connectome Project in Development, a large NIH-funded study on brain connectivity development.


SOMERVILLE, LEAH
Speaker Photo


Scott Sperling, PsyD

Staff Neuropsychologist
Cleveland Clinic

Dr. Sperling is a clinical neuropsychologist in the Center for Neurological Restoration at the Cleveland Clinic and Professor of Neurology at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. He is a clinician, educator, and researcher with expertise in Parkinson’s disease, functional neurosurgery, tele-neuropsychology, and healthcare policy. Dr. Sperling completed his doctoral training at the Wright Institute, pre-doctoral internship at the Jesse Brown VA Medical Center, and postdoctoral training in the Department of Neurology at the University of Virginia. He has a history of funded clinical research examining novel biomarkers of cognitive decline and neuropsychiatric symptoms in Parkinson’s disease and the validity of in-home tele-neuropsychological practice models. Dr. Sperling has an extensive history of professional service and is a strong advocate for clinical neuropsychology and psychology. He has served as Chair of the American Psychological Association’s (APA) Early Career Psychologist Committee and the Society for Clinical Neuropsychology’s (SCN) Education Advisory and Strategic Planning Committees. He currently serves as SCN’s Executive Director and Past-President of the Council of Specialties in Professional Psychology. Dr. Sperling has worked to advance psychology and neuropsychological practice through multiple regulatory and legislative avenues, including via his service as the Ohio Psychological Association’s Federal Advocacy Coordinator and Advocacy Committee Chair, and as the APA’s Advisor to the AMA/Specialty Society RVS Update Committee. Dr. Sperling also co-founded KnowNeuropsychology to provide a mechanism for the free and open global exchange of neuropsychological knowledge.


SPERLING, SCOTT
Speaker Photo


Melissa Sutcliffe, PhD, ABPP

Vice Chair, Division Of Neuropsychology & Rehabilitation Psychology
University Of Pittsburgh School Of Medicine Department Of Physical Medicine & Rehabilitation

Dr. Sutcliffe is the Vice Chair of the Division of Neuropsychology and Rehabilitation Psychology within the Department of Physical Medicine and Rehabilitation. She also serves as an Associate Director of the Lifespan Rehabilitation Neuropsychology Fellowship. Clinically, Dr. Sutcliffe specializes in providing inpatient and outpatient services to children, adolescents, and young adults with acquired brain injury, intractable epilepsy, and demyelinating conditions. With respect to research, Dr. Sutcliffe has served as a site Lead Neuropsychologist for several outcome studies in pediatric epilepsy surgery patients and participates in a variety of other studies looking at neurocognitive outcomes in children with complex medical conditions. She works with a variety of trainees, including undergraduate, graduate, and post- doctoral level trainees, providing a wide array of clinical experiences to help recruit and train the next generation of neuropsychologists. In addition to clinical training, Dr. Sutcliffe spends ample time teaching in the didactic setting, serving as a primary presenter in the fellowship’s annual neuroanatomy series, as well as presenting on numerous professional development topics. She is a steering committee member of the UPMC Psychology Consortium, helping with advocacy related to billing, reimbursement, and leadership development for psychologists across the system. At the national level, Dr. Sutcliffe is an active participant in the AACN mentorship program, working with trainees at varying stages of their career and guiding them towards achieving goals of becoming a board-certified neuropsychologist.


SUTCLIFFE, MELISSA
Speaker Photo


Leah Talbert, PhD

Neuropsychology Postdoctoral Fellow
VA San Diego Healthcare System

Dr. Leah D. Talbert is a Neuropsychology Postdoctoral Fellow at the VA San Diego Healthcare System and the University of California, San Diego. She earned her PhD in Clinical Psychology with a specialization in Clinical Neuropsychology from Brigham Young University. As a clinical neuropsychologist and clinical scientist, her research focuses on understanding the long-term neurological, cognitive, and behavioral consequences of traumatic brain injury (TBI) in Veterans through the integration of clinical neuroscience, epidemiology, and large-scale Veteran health data. Dr. Talbert’s research leverages the VA Million Veteran Program and VA electronic health record data to identify biological, clinical, and environmental factors associated with heterogeneous recovery following military-related TBI. The overarching goal of her research is to translate population-level epidemiologic and biomarker-informed discoveries into clinically actionable approaches that improve risk stratification, early identification, and personalized rehabilitation for Veterans living with TBI. Her current work examines the effects of combat exposure and TBI on sleep health and investigates autonomic dysfunction as a novel mechanism underlying chronic post-TBI symptom burden and long-term health outcomes. Her research integrates electronic health record phenotyping, population-based epidemiology, psychophysiology, implementation science, and multidisciplinary team science to bridge mechanistic neuroscience with real-world clinical care. Through this work, she aims to accelerate the translation of research findings into precision medicine approaches that improve the health and quality of life of Veterans.


TALBERT, LEAH
Speaker Photo


Benjamin Vandendriessche, PhD

CEO
Digital Medicine Society (DiMe)

Benjamin (Ben) Vandendriessche is CEO at the Digital Medicine Society (DiMe), dedicated to advancing digital medicine to optimize human health. His personal drive stems from the conviction that digital health technologies deployed at scale are key to developing better therapies, improving quality of care, and ultimately better patient outcomes. He has more than a decade of experience developing digital health technologies for clinical trials and care delivery, including US and EU market access and reimbursement pathways. Previously, Ben was Chief Medical Officer at health tech startup Byteflies, developing a remote patient monitoring platform for clinical trials and virtual care applications. He trained in molecular biology, systems physiology, and data analytics for vital sign processing. He completed a PhD in Molecular Biology at Ghent University as an IWT Fellow, followed by a postdoc on the interface of Critical Care Medicine and Computer Science at Case Western Reserve University (CWRU) as a BAEF Fellow. He holds an adjunct assistant professor position at CWRU and publishes regularly on all things digital medicine.


VANDENDRIESSCHE, BENJAMIN
Speaker Photo


Karin Walsh, Psy.D.

Neuropsychologist
Children's Research Institute/The George Washington University School Of Medicine & Health Sciences

Dr. Karin Scheetz Walsh, PsyD, is a Professor in the Departments of Psychiatry and Behavioral Sciences and Pediatrics at The George Washington University School of Medicine & Health Sciences and a pediatric neuropsychologist in the Division of Neuropsychology at Children’s National Hospital and the Children’s Research Institute. Dr. Walsh completed her doctoral training in psychology at Loyola University Maryland, followed by a clinical internship at Allegheny General Hospital and a fellowship in pediatric neuropsychology at the Kennedy Krieger Institute/University of Maryland Medical Center. She has been on faculty at George Washington University since 2009 and currently holds the rank of Professor. She serves as Clinical Director of the Brain Tumor Institute Neuropsychology Program, where she has led the development and implementation of innovative, evidence-based neuropsychology service models within a large academic medical center. Her work integrates clinical care, research, and training to advance prevention-based and patient-centered approaches to neuropsychological assessment and intervention. Dr. Walsh’s clinical and research program focuses on neurocognitive outcomes and interventions in children with brain tumors and neurofibromatosis type 1 (NF1), with an emphasis on clinical trials, cognitive assessment, and translational research. She has authored an extensive body of peer-reviewed publications and has contributed to multicenter and international efforts to define cognitive endpoints and best practices in pediatric neuro-oncology. She holds leadership roles in major collaborative networks, including serving as Chair of the Neurocognitive Committee for the NF Clinical Trials Consortium, with additional contributions to the Children’s Oncology Group and REiNS initiatives. Through these roles, she has helped shape standards for neurocognitive outcomes and clinical trial methodology in pediatric populations. An internationally recognized expert in pediatric neuropsychology, Dr. Walsh is a frequent invited speaker on neurocognitive outcomes, clinical trial design, and the development of evidence-based, scalable models of care for children with complex medical conditions.


WALSH, KARIN
Speaker Photo


Christopher Weber, PhD

Sr. Director, Global Science Initiatives
Alzheimer's Association

Christopher Weber, Ph.D., senior director, Global Scientific Initiatives, oversees efforts to advance the scientific agenda of the Alzheimer's Association, the world's largest nonprofit funder of Alzheimer's research, with more than $490 million invested in over 1,220 active projects in 59 countries spanning six continents. With over 20 years of clinical research experience, Dr. Weber is responsible for communicating the global research landscape of Alzheimer's and dementia, including the breadth and reach of the Association's research programs and the critical need for increased research funding from the public and private sectors. Dr. Weber directs Association initiatives that convene leaders from across the field to develop, expand and increase the success rate of Alzheimer's diagnostic tools and drugs to treat and prevent the disease. He manages the Alzheimer's Association Research Roundtable, a platform that enables international scientific, industry and government leaders to overcome shared obstacles in Alzheimer's science and drug development. He also oversees the Global Biomarker Standardization Consortium (GBSC), an initiative that unites key researchers and clinicians with industry, regulatory and government leaders to achieve consensus on the best ways to standardize and validate biomarker tests for use in clinical practices worldwide. In addition, Dr. Weber leads the Alzheimer's Association Business Consortium (AABC), which advances innovation in small- and medium-size biotechnology, diagnostics, medical device and contract organizations through pre-competitive collaborations, knowledge sharing and visibility. He also manages Association efforts as the convener of the Private Partner Scientific Board (PPSB) for ADNI4, the five-year extension of the Alzheimer's Disease Neuroimaging Initiative (ADNI) funded by the NIA with the goal of validating biomarkers for Alzheimer's disease in clinical trials. Dr. Weber received his doctorate in clinical psychology from the Illinois Institute of Technology. He holds a master's degree in kinesiology from the University of Illinois at Chicago and a bachelor's degree in psychology from the University of Wisconsin-Green Bay. In his personal time, he fundraises for Alzheimer's Association research efforts and has participated in many Ride to End ALZ® events across the United States.


WEBER, CHRISTOPHER
Speaker Photo


Tricia Williams, PhD

Neuropsychologist, Associate Scientist
Hospital For Sick Children

Dr. Tricia Williams is a Canadian Clinical Neuropsychologist and Associate Scientist at the Hospital for Sick Children, and the Garry Hurvitz Brain Health Innovator at the Center for Brain and Mental Health. Clinically, she is the chief neuropsychologist for Neonatal Neuropsychological services for assessment, consultation and intervention for children, youth and families following congenital and neonatal brain injury and associated medical conditions. In her scientific role, she leads the NeuroOutcomes Lab, where her research focuses on developing innovative ways to support brain and mental health in children with brain injury and complex medical conditions, including congenital heart disease. Trish is also a Member at Large of the INS Board of Directors.


WILLIAMS, TRICIA
Speaker Photo


Roy Yaari, MD

Associate VP-Medical • Neurodegeneration - Alzheimer's
Lilly

Roy Yaari, M.D., is an Associate Vice President-Medical, Neurodegeneration - Alzheimer's for Eli Lilly and Company. Since joining Lilly in 2013, Roy has driven progress towards Lilly’s studies in Cognitively Unimpaired Alzheimer’s disease, including decentralized trial design, structure of decentralized clinical assessments, and integration of digital innovation in neuroscience research. Prior to Lilly, Roy served as a neurologist and director of the outpatient Memory Clinic at the Banner Alzheimer’s Institute in Phoenix, AZ where he diagnosed and treated dementia patients in addition to being an investigator on numerous industry-sponsored clinical trials. Roy graduated from the University of California, Los Angeles with a degree in neuropsychology and completed his neurology residency and fellowship in Alzheimer’s and dementia at the University of California, San Diego.


YAARI, ROY
Default Photo


Roy Yaari, MD

Associate VP-Medical • Neurodegeneration - Alzheimer's
Lilly

Roy Yaari, M.D., is an Associate Vice President-Medical, Neurodegeneration - Alzheimer's for Eli Lilly and Company. Since joining Lilly in 2013, Roy has driven progress towards Lilly’s studies in Cognitively Unimpaired Alzheimer’s disease, including decentralized trial design, structure of decentralized clinical assessments, and integration of digital innovation in neuroscience research. Prior to Lilly, Roy served as a neurologist and director of the outpatient Memory Clinic at the Banner Alzheimer’s Institute in Phoenix, AZ where he diagnosed and treated dementia patients in addition to being an investigator on numerous industry-sponsored clinical trials. Roy graduated from the University of California, Los Angeles with a degree in neuropsychology and completed his neurology residency and fellowship in Alzheimer’s and dementia at the University of California, San Diego.


YAARI, ROY
Speaker Photo


Jin Zhou, MD

Executive Director
Eisai, Inc.

Jin Zhou, M.D., Ph.D.
Executive Director Clinical Development, Neurology

Jin Zhou, M.D., Ph.D., serves as Executive Director of Clinical Development, Clinical Evidence Generation, Deep Human Biology Learning at Eisai Inc. In this role, Dr. Zhou leads the company’s late phase global clinical programs in Alzheimer’s Disease and is responsible for the clinical development strategy and trial execution for anti-amyloid and anti-tau antibodies, as well as in charge of the company’s global phase 3 AHEAD 3-45 and DIAN-TU Tau Next Generation clinical trials.

Dr. Zhou has 18 years of clinical research and pharmaceutical industry experience focusing on Neurology. She has extensive regulatory submission and interaction experience with health authorities. She joined Eisai in 2019 in Clinical Research Neurology Business Group and worked in Alzheimer’s Disease area. She is also Eisai’s representative in the AD consortia and taskforce with academic and industry collaborators.

Prior to joining Eisai, Dr. Zhou held a series of clinical development positions at Daiichi Sankyo Inc., Pfizer Inc., and AstraZeneca Pharmaceuticals in Specialty Medicines and Neuroscience.

 Dr. Zhou earned her medical degree and completed neurology training at Capital Medical University in Beijing, China. She completed her Ph.D. in Neuroscience at University of Illinois at Chicago, and postdoc fellowship at Rockefeller University in New York.

 




ZHOU, JIN

 

 

 

 

 

 

Back to Top